Application of n-of-1 treatment trials in schizophrenia: systematic review

av Marwick, Katie F. M., Stevenson, Anna J., Davies, Caitlin, Lawrie, Stephen M.
I publikationen Br J Psychiatry (2018)

Application of n-of-1 treatment trials in schizophrenia: systematic review – ERRATUM

av Marwick, Katie F. M., Stevenson, Anna J., Davies, Caitlin, Lawrie, Stephen M.
I publikationen Br J Psychiatry (2018)

Functional assessment of the NMDA receptor variant GluN2A (R586K)

av Marwick, Katie F.M., Parker, Peter, Skehel, Paul, Hardingham, Giles, Wyllie, David J.A.
I publikationen Wellcome Open Res (2017)

The human NMDA receptor GluN2A(N615K) variant influences channel blocker potency

av Marwick, Katie F. M., Skehel, Paul A., Hardingham, Giles E., Wyllie, David J. A.
I publikationen Pharmacol Res Perspect (2019)

Functional assessment of triheteromeric NMDA receptors containing a human variant associated with epilepsy

av Marwick, Katie F. M., Hansen, Kasper B., Skehel, Paul A., Hardingham, Giles E., Wyllie, David J. A.
I publikationen J Physiol (2019)

The Developmental Shift of NMDA Receptor Composition Proceeds Independently of GluN2 Subunit-Specific GluN2 C-Terminal Sequences

av McKay, Sean, Ryan, Tomás J., McQueen, Jamie, Indersmitten, Tim, Marwick, Katie F.M., Hasel, Philip, Kopanitsa, Maksym V., Baxter, Paul S., Martel, Marc-André, Kind, Peter C., Wyllie, David J.A., O’Dell, Thomas J., Grant, Seth G.N., Hardingham, Giles E., Komiyama, Noboru H.
I publikationen Cell Rep (2018)

GRIN2A-related disorders: genotype and functional consequence predict phenotype

av Strehlow, Vincent, Heyne, Henrike O, Vlaskamp, Danique R M, Marwick, Katie F M, Rudolf, Gabrielle, de Bellescize, Julitta, Biskup, Saskia, Brilstra, Eva H, Brouwer, Oebele F, Callenbach, Petra M C, Hentschel, Julia, Hirsch, Edouard, Kind, Peter C, Mignot, Cyril, Platzer, Konrad, Rump, Patrick, Skehel, Paul A, Wyllie, David J A, Hardingham, Giles E, van Ravenswaaij-Arts, Conny M A, Lesca, Gaetan, Lemke, Johannes R
I publikationen Brain (2019)